GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 733 filers reported holding GLAXOSMITHKLINE PLC in Q4 2014. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $433,000 | -21.0% | 10,052 | -22.7% | 0.18% | -4.8% |
| Q1 2017 | $548,000 | -12.5% | 13,009 | -20.0% | 0.19% | -8.3% |
| Q4 2016 | $626,000 | -12.1% | 16,255 | -1.5% | 0.21% | -7.6% |
| Q3 2016 | $712,000 | +0.3% | 16,503 | +0.8% | 0.22% | -0.4% |
| Q2 2016 | $710,000 | 0.0% | 16,378 | -6.4% | 0.22% | +12.6% |
| Q1 2016 | $710,000 | +9.1% | 17,498 | +8.5% | 0.20% | +3.1% |
| Q4 2015 | $651,000 | -6.9% | 16,129 | -11.3% | 0.19% | +27.0% |
| Q3 2015 | $699,000 | -52.4% | 18,185 | -48.4% | 0.15% | -48.3% |
| Q2 2015 | $1,468,000 | -51.1% | 35,242 | -45.9% | 0.29% | -52.2% |
| Q1 2015 | $3,005,000 | +12.6% | 65,104 | +4.3% | 0.62% | +14.5% |
| Q4 2014 | $2,669,000 | +50.8% | 62,444 | +62.1% | 0.54% | +12.6% |
| Q3 2014 | $1,770,000 | -28.0% | 38,511 | -16.3% | 0.48% | -30.7% |
| Q2 2014 | $2,459,000 | +48.9% | 45,988 | +48.8% | 0.69% | +31.5% |
| Q1 2014 | $1,651,000 | -20.0% | 30,911 | -20.0% | 0.52% | -27.5% |
| Q4 2013 | $2,064,000 | +17.5% | 38,661 | +10.4% | 0.72% | +2.6% |
| Q3 2013 | $1,757,000 | +2.3% | 35,026 | +2.0% | 0.70% | -8.7% |
| Q2 2013 | $1,717,000 | – | 34,356 | – | 0.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |